| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.vineetlabs.co.in | |
| Market Cap | 50.61 Cr. | |
| Enterprise Value(EV) | 90.12 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.87 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 19.10 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 35.56 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.54 | Calculated using Price: 54.90 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.92 Cr. | 9,219,008 Shares |
| FaceValue | 10 | |
| About Vineet Laboratories Ltd. | ||
| The company is engaged in the business of Drug Intermediates & Bulk Dugs. | ||
| 1 Day |
|
+1.97% |
| 1 Week |
|
+6.52% |
| 1 Month |
|
+4.57% |
| 3 Month |
|
-21.85% |
| 6 Month |
|
+7.94% |
| 1 Year |
|
+13.20% |
| 2 Year |
|
-18.24% |
| 5 Year |
|
|
| 10 Year |
|
| 6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0 | 0 | -2.87 | 13.18 | 22.19 | 3.74 | |
| Return on Capital Employed (%) | 0 | 0 | -2.87 | 34.06 | 23.14 | 8.69 | |
| Return on Assets (%) | 0 | 0 | -2.72 | 3.26 | 5.49 | 1.01 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 0 | 0 | 0 | 27 | 33 | 34 | 35 | |
| Non Curr. Liab. | 7 | 5 | 8 | 7 | ||||
| Curr. Liab. | 0 | 0 | 75 | 95 | 75 | 80 | ||
| Minority Int. | ||||||||
| Equity & Liab. | 0 | 0 | 0 | 109 | 133 | 116 | 122 | |
| Non Curr. Assets | 22 | 31 | 28 | 28 | ||||
| Curr. Assets | 0 | 0 | 0 | 86 | 103 | 87 | 94 | |
| Misc. Exp. not W/O | 0 | 0 | ||||||
| Total Assets | 0 | 0 | 0 | 109 | 133 | 116 | 122 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 243 | 191 | 212 | 171 | ||||
| Other Income | 0 | 0 | 0 | 0 | ||||
| Total Income | 244 | 191 | 212 | 171 | ||||
| Total Expenditure | 0 | -235 | -178 | -205 | -161 | |||
| PBIDT | 0 | 9 | 13 | 8 | 10 | |||
| Interest | -3 | -2 | -3 | -3 | ||||
| Depreciation | -2 | -2 | -2 | -2 | ||||
| Taxation | -2 | -3 | -1 | -1 | ||||
| Exceptional Items | ||||||||
| PAT | 0 | 2 | 7 | 1 | 3 | |||
| Adjusted EPS | 0 | 2 | 7 | 1 | 3 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 27 | 8 | -10 | ||||
| Cash Fr. Inv. | -8 | -4 | -7 | ||||
| Cash Fr. Finan. | 19 | 12 | 0 | ||||
| Net Change | 38 | 16 | -16 | ||||
| Cash & Cash Eqvt | 38 | 17 | 1 |
|
Mon, 22 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Ramesh Kumar Bandari Designation: Company Secretary and Compliance Officer EmailId: cs@vineetlabs.co.in Name of the Chief Financial Officer: Satyanarayana Raju Bhupathiraju Designation: Chief Financial Officer EmailId: bhsnraju6969@gmail.com Date: 22/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
|
Sat, 13 Apr 2024
Certificate Under Regulation 40(9) And 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 We are hereby enclosing the certificate received from the Practicing Company Secretary for the financial year ended on March 31 2024. |
|||||||||||||||||||||
|
Fri, 12 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 We are hereby submitting the certificate issued by Venture capital and Corporate Investments Private Limited for the fourth quarter and financial year ended on March 31 2024 |
| Thu, 25 Apr 2024 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Opening at High
|
Closing Above Previous High
|
